INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design

PHASE4CompletedINTERVENTIONAL
Enrollment

3,109

Participants

Timeline

Start Date

April 11, 2018

Primary Completion Date

October 10, 2019

Study Completion Date

October 10, 2019

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

FF/UMEC/VI

FF is a dry white powder containing 100 mcg GW685698 blended with lactose in one blister in the first strip of the DPI. UMEC/VI is a dry white powder containing 62.5 mcg of UMEC and 25 mcg of VI per blister, both blended together with lactose and magnesium stearate in the second strip of the DPI.

DRUG

Inhaled Corticosteroid

Inhaled Corticosteroid (ICS) as prescribed by the physician.

DRUG

LAMA

LAMA as prescribed by the physician.

DRUG

LABA

LABA as prescribed by the physician.

DRUG

COPD rescue medications

Rescue medications for COPD will be prescribed and obtained according to usual practice.

Trial Locations (143)

10003

GSK Investigational Site, Cáceres

10009

GSK Investigational Site, Cadiz

10119

GSK Investigational Site, Berlin

10367

GSK Investigational Site, Berlin

10625

GSK Investigational Site, Berlin

10717

GSK Investigational Site, Berlin

10969

GSK Investigational Site, Berlin

11446

GSK Investigational Site, Stockholm

12159

GSK Investigational Site, Berlin

12203

GSK Investigational Site, Berlin

13086

GSK Investigational Site, Berlin

13156

GSK Investigational Site, Berlin

13187

GSK Investigational Site, Berlin

14059

GSK Investigational Site, Berlin

14467

GSK Investigational Site, Potsdam

14469

GSK Investigational Site, Potsdam

15517

GSK Investigational Site, Fürstenwalde

15562

GSK Investigational Site, Rüdersdorf

18300

GSK Investigational Site, Loja/ Granada

21502

GSK Investigational Site, Geesthacht

22299

GSK Investigational Site, Hamburg

23558

GSK Investigational Site, Lübeck

24404

GSK Investigational Site, Ponferrada (León)

24837

GSK Investigational Site, Schleswig

26006

GSK Investigational Site, Logroño

26203

GSK Investigational Site, Wardenburg

28040

GSK Investigational Site, Madrid

28223

GSK Investigational Site, Pozuelo de Alarcón/Madrid

28850

GSK Investigational Site, Torrejón de Ardoz

28922

GSK Investigational Site, Alcorcón (Madrid)

29603

GSK Investigational Site, Marbella - Málaga

29630

GSK Investigational Site, Benalmádena, Málaga

30167

GSK Investigational Site, Hanover

30173

GSK Investigational Site, Hanover

31224

GSK Investigational Site, Peine

35037

GSK Investigational Site, Marburg

36039

GSK Investigational Site, Fulda

36312

GSK Investigational Site, Vigo-Pontevedra

39770

GSK Investigational Site, Laredo

40002

GSK Investigational Site, Segovia

41009

GSK Investigational Site, Seville

45355

GSK Investigational Site, Essen

45359

GSK Investigational Site, Essen

45879

GSK Investigational Site, Gelsenkirchen

46600

GSK Investigational Site, Alzira/Valencia

48013

GSK Investigational Site, Basurto/Bilbao

48231

GSK Investigational Site, Warendorf

48431

GSK Investigational Site, Rheine

50009

GSK Investigational Site, Zaragoza

51069

GSK Investigational Site, Cologne

51429

GSK Investigational Site, Bergisch Gladbach

53119

GSK Investigational Site, Bonn

56068

GSK Investigational Site, Koblenz

60389

GSK Investigational Site, Frankfurt am Main

60596

GSK Investigational Site, Frankfurt am Main

63110

GSK Investigational Site, Rodgau

63739

GSK Investigational Site, Aschaffenburg

64283

GSK Investigational Site, Darmstadt

65428

GSK Investigational Site, Rüsselsheim am Main

82467

GSK Investigational Site, Garmisch-Partenirchen

85221

GSK Investigational Site, Dachau

94469

GSK Investigational Site, Deggendorf

94574

GSK Investigational Site, Wallerfing

03050

GSK Investigational Site, Cottbus

04509

GSK Investigational Site, Delitzsch

04103

GSK Investigational Site, Leipzig

04157

GSK Investigational Site, Leipzig

04207

GSK Investigational Site, Leipzig

04275

GSK Investigational Site, Leipzig

04357

GSK Investigational Site, Leipzig

06108

GSK Investigational Site, Halle

06682

GSK Investigational Site, Teuchern

04626

GSK Investigational Site, Schmölln

1815 JD

GSK Investigational Site, Alkmaar

4818 CK

GSK Investigational Site, Breda

3318 AT

GSK Investigational Site, Dordrecht

9718 AW

GSK Investigational Site, Groningen

9728 NT

GSK Investigational Site, Groningen

3844 DG

GSK Investigational Site, Harderwijk

6419 PC

GSK Investigational Site, Heerlen

7555 DL

GSK Investigational Site, Hengelo

1624 NP

GSK Investigational Site, Hoorn

7694 AC

GSK Investigational Site, Kloosterhaar

6532 SZ

GSK Investigational Site, Nijmegen

3045 PM

GSK Investigational Site, Rotterdam

3051 GV

GSK Investigational Site, Rotterdam

3083 AN

GSK Investigational Site, Rotterdam

3703 CD

GSK Investigational Site, Zeist

7207 AE

GSK Investigational Site, Zutphen

08003

GSK Investigational Site, Barcelona

08023

GSK Investigational Site, Barcelona

08035

GSK Investigational Site, Barcelona

08907

GSK Investigational Site, L'Hospitalet de Llobregat. Barcelona

08430

GSK Investigational Site, La Roca Del Valles (Barcelona)

07010

GSK Investigational Site, Palma de Mallorca

SE-424 22

GSK Investigational Site, Angered

SE-642 37

GSK Investigational Site, Flen

SE-413 90

GSK Investigational Site, Gothenburg

SE-417 17

GSK Investigational Site, Gothenburg

SE-418 73

GSK Investigational Site, Gothenburg

SE-871 82

GSK Investigational Site, Härnösand

SE-236 51

GSK Investigational Site, Höllviken

SE-291 85

GSK Investigational Site, Kristianstad

SE-434 80

GSK Investigational Site, Kungsbacka

SE-971 89

GSK Investigational Site, Luleå

SE-205 02

GSK Investigational Site, Malmo

SE- 591 85

GSK Investigational Site, Motala

SE-703 62

GSK Investigational Site, Örebro

SE-831 83

GSK Investigational Site, Östersund

SE-152 86

GSK Investigational Site, Södertälje

SE-113 61

GSK Investigational Site, Stockholm

SE-461 73

GSK Investigational Site, Trollhättan

CB7 5JD

GSK Investigational Site, Soham

SA14 8QF

GSK Investigational Site, Llanelli

SK10 5JH

GSK Investigational Site, Bollington

SK11 6JL

GSK Investigational Site, Macclesfield

CW11 1EQ

GSK Investigational Site, Sandbach

LL18 1DA

GSK Investigational Site, Rhyl

PO8 8DL

GSK Investigational Site, Waterlooville

ML2 0DP

GSK Investigational Site, Wishaw

NN17 2UR

GSK Investigational Site, Corby

NN8 4RW

GSK Investigational Site, Wellingborough

IP16 4ES

GSK Investigational Site, Leiston

TN40 1JJ

GSK Investigational Site, Bexhill-on-Sea

NE8 2PQ

GSK Investigational Site, Gateshead

CH63 9JP

GSK Investigational Site, Bebington

CH7 3HB

GSK Investigational Site, Buckley

CF23 9PN

GSK Investigational Site, Cardiff

CF3 3LG

GSK Investigational Site, Cardiff

CO2 7GH

GSK Investigational Site, Colchester

NE45 5LG

GSK Investigational Site, Corbridge

TR27 5DT

GSK Investigational Site, Cornwall

EH16 4SA

GSK Investigational Site, Edinburgh

HU12 8JD

GSK Investigational Site, Hull

M44 5LH

GSK Investigational Site, Irlam, Manchester

FK5 4WR

GSK Investigational Site, Larbet

M28 1PB

GSK Investigational Site, Manchester

NP20 4SZ

GSK Investigational Site, Newport

PO30 5TG

GSK Investigational Site, Newport, Isle of Wight

BH15 2HX

GSK Investigational Site, Poole

SO16 6YD

GSK Investigational Site, Southampton

M27 4AF

GSK Investigational Site, Swinton

WA2 7NJ

GSK Investigational Site, Warrington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT03467425 - INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design | Biotech Hunter | Biotech Hunter